JPRN-UMIN000039350尚未招募未知
Clinical benefit of pemafibrate in patients with primary biliary cholangitis (PBC) with dyslipidemia - Clinical benefit of pemafibrate in patients with primary biliary cholangitis (PBC) with dyslipidemia
Shinshu University Faculty of Medicine, Department of Gastroenterology0 个研究点目标入组 60 人开始时间: 2020年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclude patients who meet the following criteria 1) Patients who have already taken pemafibrate 2) Preexisting disorders of being allergic to pemafibrate 3) Pregnant women or breast-feeding women 4) Patients who have already taken statins. 5) Patients by whom principal investigator has determined to be inappropriate as a subject
研究者
相似试验
招募中
不适用
Safety and efficacy of pemafibrate (Parmodia) for patients having dyslipidemia and non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000035248Shinshu University School of Medicine20
招募中
Unknown
The efficacy and safety of the pemafibrate in subjects with dyslipidemia and severely decreased renal function; a prospective observational studyDyslipidemia, chronic kidney diseaseJPRN-UMIN000053168Kushiro Red Cross Hospital60
招募中
2 期
Randomized controlled trial of pemafibrate and fenofibrate for NAFLD with hypertriglyceridemiaJPRN-jRCTs031200280Iwaki Michihiro360
已完成
Unknown
A single-arm study of the efficacy of pemafibrate in patients with NAFLD (non-alcoholic fatty liver disease) complicated by dyslipidemiaAFLD (non-alcoholic fatty liver disease) complicated by dyslipidemiaJPRN-UMIN000049937ippon Medical School, gastroenterology, Hiroki Ono91
已完成
不适用
Effect of addition of pemafibrate and double dose of statin on small dense LDL cholesterol in statin-treated patients with type 2 diabetes and hypertriglyceridemia: A comparative Study.HypertriglyceridemiaJPRN-jRCTs031190232Mori Yusaku102